SARCOMA CONNECT has summarised the highlights from ASCO 2019 for you. Soft-tissue Sarcoma, Osteosarcoma and GIST by Dr Robin L. Jones, Royal Marsden Hospital, Institute of Cancer Research, London, UK
Robin Jones is a medical oncologist specialising in the treatment of bone and soft tissue sarcomas and Head of the Sarcoma Unit at The Royal Marsden. He has experience in conducting Phase I, II and III trials, as well translational studies in sarcomas. Professor Jones trained in medical oncology at The Royal Marsden and between 2010 and 2014 he was Head of the Sarcoma Program at the University of Washington/Fred Hutchinson Cancer Research Center in Seattle. His main research interest focuses on clinical trials and translational research in sarcomas
Programme summary
-
Duration
5 MIN
-
Language(s)
Brought to you by
SARCOMA CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Karyopharm Therapeutics.
Meet the experts
Other programmes of interest
Symposium
Oncology
ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium
Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer
Experts
Prof. Wolfgang Janni, Prof. Sherko Kümmel, Prof. Michail Ignatiadis-
Downloadable
Resources -
5 MIN
-
May 2025
Podcast
Hemostasis and bleeding disorders Oncology
Serie de podcasturi referitoare la gestionarea trombozei
Experți de renume din domeniul medical își împărtășesc perspectivele. Navigați în secțiuni pentru a selecta un episod al podcastului
Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis, Prof. Jerzy Windyga, Prof. Daniel Bolliger-
Downloadable
Resources -
21 MIN
-
May 2025
Video
Oncology Hemato-oncology
Optimising the sequence of novel therapies from early relapse in multiple myeloma
Improving the survival of patients with relapsed/refractory multiple myeloma
Experts
Prof. Hermann Einsele, Prof. Evangelos Terpos-
Downloadable
Resources -
2 MIN
-
May 2025
Animated Video
Oncology
BRAF V600E mutated NSCLC: The evolving treatment landscape
Expert insights into personalised treatment strategies in BRAF-mutated NSCLC
Experts
Prof. Amanda TufmanEndorsed by
-
Downloadable
Resources -
6 MIN
-
May 2025
Podcast
Oncology
Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC)
Chemotherapy strategies that matter
Experts
Prof. Shubham Pant, Prof. Efrat DotanEndorsed by
-
Downloadable
Resources -
4 MIN
-
May 2025
Podcast
Oncology
Understanding rare non-small cell lung cancer (NSCLC) alterations
Insights and support for patients
Experts
Dr Joshua Sabari, Debra MontagueEndorsed by
-
Downloadable
Resources -
4 MIN
-
May 2025